RVL Pharmaceuticals plc Quarterly Earnings Per Share, Diluted in USD/shares from Q2 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
RVL Pharmaceuticals plc quarterly/annual Earnings Per Share, Diluted history and growth rate from Q2 2020 to Q2 2023.
  • RVL Pharmaceuticals plc Earnings Per Share, Diluted for the quarter ending June 30, 2023 was -0.24 USD/shares, a 71.4% decline year-over-year.
  • RVL Pharmaceuticals plc Earnings Per Share, Diluted for the twelve months ending June 30, 2023 was -0.72 USD/shares, a 4% increase year-over-year.
  • RVL Pharmaceuticals plc annual Earnings Per Share, Diluted for 2022 was -0.58 USD/shares, a 39.6% increase from 2021.
  • RVL Pharmaceuticals plc annual Earnings Per Share, Diluted for 2021 was -0.96 USD/shares, a 26.7% increase from 2020.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$1 $0 $0 -71.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$1 $0 $0 -50% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$1 $0 +$0.05 +20% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-20
Q3 2022 -$1 $0 +$0.12 +42.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 -$1 $0 +$0.14 +50% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$1 $0 +$0.07 +46.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$1 $0 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 $0 $0 -100% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $0 $0 -27.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.